An Open Label Study of Multiple Doses of Cannabidiol in the Prevention of Acute Graft-Versus-Host Disease (GVHD)
Clinical trial NCT03840512 · UNKNOWN
Trial details
- NCT number
- NCT03840512
- Sponsor
- Kalytera Therapeutics Israel, Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-12
- Primary completion
- 2022-11-15
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.